会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明申请
    • RAPID ACTING INSULIN ANALOGUES
    • 快速行动胰岛素类似物
    • WO2009021956A3
    • 2009-04-30
    • PCT/EP2008060597
    • 2008-08-12
    • NOVO NORDISK ASOLSEN HELLE BIRKKJELDSEN THOMAS BOERGLUMBALSCHMIDT PERGLENDORF TINEHAVELUND SVEND
    • OLSEN HELLE BIRKKJELDSEN THOMAS BOERGLUMBALSCHMIDT PERGLENDORF TINEHAVELUND SVEND
    • C07K14/62
    • C07K14/62
    • The invention is related to fast acting insulin analogues which can form soluble mixtures (pre-mixed or self-mixed) with long acting insulin analogues. The fast action is achieved through monomerizing substitutions/deletions in the C-terminus of the B-chain of human insulin and the mixability with long acting insulin analogues is achieved through a substitution of the Zn-binding H is in position B10 of human insulin with lie, VaI, Ala or Phe. In one embodiment the invention is related to fast acting insulin analogues in which at least one of the natural amino acid residues in position B22-B30 in the human B-chain has been substituted with another amino acid residue having the effect of promoting formation of the monomeric form of insulin, the H is amino acid residue in position 10 in the B-chain is substituted with lie, VaI, Ala or Phe and wherein further one or more of the amino acid residues in position B22-B30 optionally have been deleted.
    • 本发明涉及可与长效胰岛素类似物形成可溶性混合物(预混合或自混合)的快速作用胰岛素类似物。 通过在人胰岛素的B链的C末端单体化取代/缺失实现快速作用,并且通过用人胰岛素B10位置上的Zn结合H取代与长效胰岛素类似物的混合性来实现, ,Val,Ala或Phe。 在一个实施方案中,本发明涉及快速作用的胰岛素类似物,其中人B链中位置B22-B30中的至少一个天然氨基酸残基已经被另一个氨基酸残基取代,其具有促进形成 单体形式的胰岛素,H是B链中位置10的氨基酸残基被取代为,Val,Ala或Phe,并且其中一个或多个位置B22-B30的氨基酸残基任选地被缺失。